Incretin mimetic explained

Incretin mimetic can refer to any drug that mimics the actions of one or more incretin hormones. They are used for type 2 diabetes.^{[1] [2]}

Specific incretin mimetics include:

• Dipeptidyl peptidase-4 inhibitor
• GLP-1 receptor agonist

Notes and References

1. Web site: Research . Center for Drug Evaluation and . Incretin mimetic drugs for type 2 diabetes . FDA . 5 November 2023 . en . 2 March 2022.
2. Web site: Incretin Based Treatments . Diabetes Education Online . 5 November 2023.